731 related articles for article (PubMed ID: 20219615)
1. Molecular advances in autosomal dominant polycystic kidney disease.
Gallagher AR; Germino GG; Somlo S
Adv Chronic Kidney Dis; 2010 Mar; 17(2):118-30. PubMed ID: 20219615
[TBL] [Abstract][Full Text] [Related]
2. The heteromeric PC-1/PC-2 polycystin complex is activated by the PC-1 N-terminus.
Ha K; Nobuhara M; Wang Q; Walker RV; Qian F; Schartner C; Cao E; Delling M
Elife; 2020 Nov; 9():. PubMed ID: 33164752
[TBL] [Abstract][Full Text] [Related]
3. Genetic Mechanisms of ADPKD.
Kim DY; Park JH
Adv Exp Med Biol; 2016; 933():13-22. PubMed ID: 27730431
[TBL] [Abstract][Full Text] [Related]
4. Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and potential therapies.
Mochizuki T; Tsuchiya K; Nitta K
Clin Exp Nephrol; 2013 Jun; 17(3):317-26. PubMed ID: 23192769
[TBL] [Abstract][Full Text] [Related]
5. Cilia and polycystic kidney disease.
Ma M
Semin Cell Dev Biol; 2021 Feb; 110():139-148. PubMed ID: 32475690
[TBL] [Abstract][Full Text] [Related]
6. Molecular dysregulation of ciliary polycystin-2 channels caused by variants in the TOP domain.
Vien TN; Wang J; Ng LCT; Cao E; DeCaen PG
Proc Natl Acad Sci U S A; 2020 May; 117(19):10329-10338. PubMed ID: 32332171
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of autosomal dominant polycystic kidney disease.
Al-Bhalal L; Akhtar M
Adv Anat Pathol; 2005 May; 12(3):126-33. PubMed ID: 15900113
[TBL] [Abstract][Full Text] [Related]
8. Autosomal dominant polycystic kidney disease: clues to pathogenesis.
Harris PC
Hum Mol Genet; 1999; 8(10):1861-6. PubMed ID: 10469838
[TBL] [Abstract][Full Text] [Related]
9. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
Boucher C; Sandford R
Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Hedgehog signaling suppresses proliferation and microcyst formation of human Autosomal Dominant Polycystic Kidney Disease cells.
Silva LM; Jacobs DT; Allard BA; Fields TA; Sharma M; Wallace DP; Tran PV
Sci Rep; 2018 Mar; 8(1):4985. PubMed ID: 29563577
[TBL] [Abstract][Full Text] [Related]
11. Polycystic kidney disease: novel insights into polycystin function.
Luo L; Roy S; Li L; Ma M
Trends Mol Med; 2023 Apr; 29(4):268-281. PubMed ID: 36805211
[TBL] [Abstract][Full Text] [Related]
12. A polycystin-centric view of cyst formation and disease: the polycystins revisited.
Ong AC; Harris PC
Kidney Int; 2015 Oct; 88(4):699-710. PubMed ID: 26200945
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathogenesis of autosomal dominant polycystic kidney disease.
Yoder BK; Mulroy S; Eustace H; Boucher C; Sandford R
Expert Rev Mol Med; 2006 Jan; 8(2):1-22. PubMed ID: 16515728
[TBL] [Abstract][Full Text] [Related]
14. The pathogenesis of autosomal dominant polycystic kidney disease: an update.
Somlo S; Markowitz GS
Curr Opin Nephrol Hypertens; 2000 Jul; 9(4):385-94. PubMed ID: 10926175
[TBL] [Abstract][Full Text] [Related]
15. Cyclin-Dependent Kinase 1 Activity Is a Driver of Cyst Growth in Polycystic Kidney Disease.
Zhang C; Balbo B; Ma M; Zhao J; Tian X; Kluger Y; Somlo S
J Am Soc Nephrol; 2021 Jan; 32(1):41-51. PubMed ID: 33046531
[TBL] [Abstract][Full Text] [Related]
16. Genetic reduction of cilium length by targeting intraflagellar transport 88 protein impedes kidney and liver cyst formation in mouse models of autosomal polycystic kidney disease.
Shao L; El-Jouni W; Kong F; Ramesh J; Kumar RS; Shen X; Ren J; Devendra S; Dorschel A; Wu M; Barrera I; Tabari A; Hu K; Haque N; Yambayev I; Li S; Kumar A; Behera TR; McDonough G; Furuichi M; Xifaras M; Lu T; Alhayaza RM; Miyabayashi K; Fan Q; Ajay AK; Zhou J
Kidney Int; 2020 Nov; 98(5):1225-1241. PubMed ID: 32610050
[TBL] [Abstract][Full Text] [Related]
17. Somatic Mutations in Renal Cyst Epithelium in Autosomal Dominant Polycystic Kidney Disease.
Tan AY; Zhang T; Michaeel A; Blumenfeld J; Liu G; Zhang W; Zhang Z; Zhu Y; Rennert L; Martin C; Xiang J; Salvatore SP; Robinson BD; Kapur S; Donahue S; Bobb WO; Rennert H
J Am Soc Nephrol; 2018 Aug; 29(8):2139-2156. PubMed ID: 30042192
[TBL] [Abstract][Full Text] [Related]
18. Polycystin-2-dependent transcriptome reveals early response of autosomal dominant polycystic kidney disease.
Jung HJ; Dixon EE; Coleman R; Watnick T; Reiter JF; Outeda P; Cebotaru V; Woodward OM; Welling PA
Physiol Genomics; 2023 Nov; 55(11):565-577. PubMed ID: 37720991
[TBL] [Abstract][Full Text] [Related]
19. Vascular polycystin proteins in health and disease.
Mbiakop UC; Jaggar JH
Microcirculation; 2024 May; 31(4):e12834. PubMed ID: 37823335
[TBL] [Abstract][Full Text] [Related]
20. Cell-Autonomous Hedgehog Signaling Is Not Required for Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
Ma M; Legué E; Tian X; Somlo S; Liem KF
J Am Soc Nephrol; 2019 Nov; 30(11):2103-2111. PubMed ID: 31451534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
